Aterian, Inc. Form 8-K Summary
Business Context and Reporting Period
Aterian, Inc. filed this Current Report on Form 8-K on March 4, 2022, reporting material financing agreements entered into on March 1, 2022. The private placement closed on March 4, 2022. The filing does not provide operating results or financial statements for a reporting period.
Financing and Key Financial Terms
- The company raised approximately $27.5 million in gross proceeds through a private placement to accredited investors.
- Investors received 6,436,322 shares of common stock and warrants to purchase 4,827,242 shares.
- Investors also received pre-funded warrants for up to 3,013,850 shares and accompanying warrants to purchase 2,260,388 shares.
- Shares and accompanying warrants were sold at a combined price of $2.91. Pre-funded warrants and accompanying warrants were sold at a combined price of $2.9099.
- Pre-funded warrants have an exercise price of $0.0001 per share and became immediately exercisable.
- Common stock warrants have an exercise price of $3.20 per share, become exercisable on or after September 6, 2022, and expire on September 7, 2027.
- The warrants include beneficial ownership limitations generally ranging from 4.99% to 9.99%, subject to the terms of the instruments.
- The placement agent, Craig-Hallum Capital Group LLC, received compensation equal to 6.0% of gross proceeds in the form of 567,010 shares and warrants to purchase up to 425,258 shares.
- The filing does not provide a clear amount for net proceeds after placement agent compensation and other offering expenses.
Use of Proceeds, Material Changes, and Outlook
Aterian expects to use the proceeds for working capital, general corporate purposes, operating expenses, capital expenditures, and potentially acquisitions, investments in or licenses of complementary products, technologies, or businesses. The filing does not provide revenue, profit, cash flow, margin, debt, liquidity, or operating guidance metrics.
The financing increases the company’s cash resources but also creates substantial potential dilution from the issued shares, pre-funded warrants, common stock warrants, and placement agent securities. The filing does not quantify the resulting fully diluted share count.
Registration Rights, Contingencies, and Risks
- Aterian agreed to file a resale registration statement for the issued shares and warrant shares within 30 days after March 1, 2022, and to use commercially reasonable efforts to make it effective and keep it effective during the required period.
- Failure to meet specified registration milestones or maintain an effective registration statement may require liquidated damages of 1.0% of the applicable investment for each 30-day period, subject to a maximum of 6.0%.
- The company agreed, subject to exceptions, not to issue or announce the issuance of common stock or common stock equivalents for 60 days after the applicable resale registration statement becomes effective.
- Common stock warrants include provisions relating to fundamental transactions, including potential repurchase rights based on a Black-Scholes valuation formula in certain circumstances.
- The securities were issued in an unregistered private placement under Section 4(a)(2) and/or Rule 506 of Regulation D. The securities may not be resold absent registration or an applicable exemption.
- Management’s statements regarding use of proceeds are forward-looking and subject to risks involving the company’s financial position, market conditions, and risks disclosed in other SEC filings.
Important Facts for Investors to Verify
- Confirm the final net cash proceeds after placement agent compensation and transaction expenses.
- Review subsequent filings for the resale registration statement’s filing and effectiveness dates and any liquidated damages.
- Assess dilution from all issued shares, pre-funded warrants, common stock warrants, and placement agent securities.
- Verify the number of warrants exercised, outstanding, or expired and the resulting share count.
- Review Aterian’s subsequent periodic reports for liquidity, cash-burn trends, debt obligations, operating performance, and use of the financing proceeds.